US Stock MarketDetailed Quotes

VTRS Viatris

Watchlist
  • 12.520
  • +0.390+3.22%
Close Dec 20 16:00 ET
  • 12.400
  • -0.120-0.96%
Post 20:01 ET
14.94BMarket Cap-17.15P/E (TTM)

About Viatris Company

Viatris, Inc. is a global healthcare company, which engages in the provision of access to medicines and sustainable operations. It also offers support services such as diagnostic clinics, educational seminars, and digital tools. The firm operates through the following segments: Developed Markets, Greater China, JANZ, and Emerging Markets. The Developed Markets segment consists of operations primarily in North America and Europe. The Greater China segment includes operations in mainland China, Taiwan and Hong Kong. The JANZ segment consists of operations in Japan, Australia and New Zealand. The Emerging Markets segment encompasses operations with developing markets and emerging economies including countries in Asia, the Middle East, South and Central America, Africa and Eastern Europe. The company was founded on February 14, 2019 and is headquartered in Canonsburg, PA.

Company Profile

SymbolVTRS
Company NameViatris
Listing DateFeb 1, 1973
Founded2019
CEOMr. Scott A. Smith
MarketNASDAQ
Employees38000
Fiscal Year Ends12-31
AddressRobert J. Coury Global Center,1000 Mylan Boulevard
CityCanonsburg
ProvincePennsylvania
CountryUnited States of America
Zip Code15317
Phone1-724-514-1800

Company Executives

  • Name
  • Position
  • Salary
  • Scott A. Smith
  • Director and Chief Executive Officer
  • 15.93M
  • Dr. Corinne Le Goff, Pharm.D.
  • Chief Commercial Officer
  • --
  • Theodora Mistras
  • Chief Financial Officer
  • --
  • Paul B. Campbell
  • Chief Accounting Officer and and Corporate Controller
  • --
  • Brian Roman
  • Chief Legal Officer
  • 4.11M
  • Robert J. Coury
  • Chairman Emeritus
  • 41.50M
  • Mark W. Parrish
  • Vice Chairman of the Board
  • 450.01K
  • Melina E. Higgins
  • Chairman of the Board
  • 454.38K
  • Rajiv Malik
  • Director
  • 12.48M
  • Elisha W. Finney
  • Independent Director
  • 370.01K
  • Wyllie Don Cornwell
  • Independent Director
  • 370.01K
  • Dr. Rogerio Vivaldi Coelho, M.B.A.,M.D.
  • Independent Director
  • --
  • Harry A. Korman
  • Independent Director
  • 375.01K
  • Richard A. Mark, C.P.A.
  • Independent Director
  • 420.01K
  • James M. Kilts
  • Independent Director
  • 370.01K
  • Leo Groothuis
  • Independent Director
  • 313.54K
  • JoEllen Lyons Dillon
  • Independent Director
  • 400.01K
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.